Etiology, clinical manifestations, and prediction of placental abruption

References

• Faye-Petersen OM, Heller DS, Joshi VV. Gross abnormalities of the placenta: lesions due to disturbances of maternal and of fetal blood flow. In: Handbook of placental pathology. 2nd edn. Oxon, UK: Taylor & Francis, 2006. pp. 27–51s.
   Google Scholar
• Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol. 2006;108:1005–16.
   PubMed Web of Science ®Google Scholar
• Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O. Clinical presentation and risk factors of placental abruption. Acta Obstet Gynecol Scand. 2006;85:700–5.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Getahun D, Peltier MR, Smulian JC. Placental abruption in term and preterm gestations: evidence for heterogeneity in clinical pathways. Obstet Gynecol. 2006;107:785–92.
   PubMed Web of Science ®Google Scholar
• Kramer MS, Usher RH, Pollack R, Boyd M, Usher S. Etiologic determinants of abruptio placentae. Obstet Gynecol. 1997;89:221–6.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Savitz DA, Bowes WA Jr, Luther ER. Influence of hypertensive disorders and cigarette smoking on placental abruption and uterine bleeding during pregnancy. BJOG. 1997;104:572–8.
   Google Scholar
• Rasmussen S, Irgens LM, Dalaker K. A history of placental dysfunction and risk of placental abruption. Paediatr Perinat Epidemiol. 1999;13:9–21.
   PubMed Web of Science ®Google Scholar
• Kraus FT, Redline RW, Gersell DJ, Nelson DM, Dicke JM. Disorders of placental development. In: Placental pathology. Atlas of nontumor pathology. Washington, DC: The American Registry of Pathology, 2004. pp. 47–74.
   Google Scholar
• Ananth CV, Oyelese Y, Prasad V, Getahun D, Smulian JC. Evidence of placental abruption as a chronic process: associations with vaginal bleeding early in pregnancy and placental lesions. Eur J Obstet Gynecol Reprod Biol. 2006;128:15–21.
   PubMed Web of Science ®Google Scholar
• Matthiesen L, Berg G, Ernerudh J, Skogh T. Lymphocyte subsets and autoantibodies in pregnancies complicated by placental disorders. Am J Reprod Immunol. 1995;33:31–9.
   PubMedGoogle Scholar
• Steinborn A, Rebmann V, Scharf A, Sohn C, Grosse-Wilde H. Soluble HLA-DR levels in the maternal circulation of normal and pathologic pregnancy. Am J Obstet Gynecol. 2003;188:473–9.
   PubMedGoogle Scholar
• Matthiesen L, Berg G, Ernerudh J, Ekerfelt C, Jonsson Y, Sharma S. Immunology of preeclampsia. Chem Immunol Allergy. 2005;89:49–61.
   PubMedGoogle Scholar
• Nakatsuka M, Asagiri K, Kimura Y, Kamada Y, Tada K, Kudo T. Generation of peroxynitrite and apoptosis in placenta of patients with chorioamnionitis: possible implications in placental abruption. Hum Reprod. 1999;14:1101–6.
   PubMed Web of Science ®Google Scholar
• Eskes TK. Abruptio placentae. A “classic” dedicated to Elizabeth Ramsey. Eur J Obstet Gynecol Reprod Biol. 1997;75:63–70.
   Google Scholar
• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592–4.
   PubMed Web of Science ®Google Scholar
• Zygmunt M, Herr F, Munstedt K, Lang U, Liang OD. Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2003;110:S10–18.
   PubMed Web of Science ®Google Scholar
• Lambert-Messerlian GM, Canick JA. Placenta growth factor levels in second-trimester maternal serum in Down syndrome pregnancy and in the prediction of preeclampsia. Prenat Diagn. 2004;24:876–80.
   Google Scholar
• Lam C, Lim KH, Karumanchi SA. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension. 2005;46:1077–85.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Karumanchi SA. Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol. 2005;48:372–86.
   PubMed Web of Science ®Google Scholar
• Nolan TE, Smith RP, Devoe LD. A rapid test for abruptio placentae: evaluation of a D-dimer latex agglutination slide test. Am J Obstet Gynecol. 1993;169:265–8.
   Google Scholar
• Bartha JL, Comino-Delgado R, Arce F. Maternal serum alpha-fetoprotein in placental abruption associated with preterm labor. Int J Gynaecol Obstet. 1997;56:231–6.
   Google Scholar
• Chandra S, Scott H, Dodds L, Watts C, Blight C, Van Den Hof M. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes. Am J Obstet Gynecol. 2003;189:775–81.
   PubMed Web of Science ®Google Scholar
• Florio P, Severi FM, Bocchi C, Luisi S, Petraglia F. Abruptio placentae and highest maternal serum activin A levels at mid-gestation: a two cases report. Placenta. 2003;24:279–80.
   Google Scholar
• Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol. 2005;106:260–7.
   PubMed Web of Science ®Google Scholar
• Signore C, Mills JL, Qian C, Yu K, Lam C, Epstein FH, Circulating angiogenic factors and placental abruption. Obstet Gynecol. 2006;108:338–4.
   PubMed Web of Science ®Google Scholar
• Tikkanen M, Hämäläinen E, Nuutila M, Paavonen J, Ylikorkala O, Hiilesmaa V. Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption. Prenat Diagn. 2007;27:240–3.
   PubMed Web of Science ®Google Scholar
• Tikkanen M, Stenman U-H, Nuutila M, Paavonen J, Hiilesmaa V, Ylikorkala O. Failure of second-trimester measurement of soluble endoglin and other angiogenic factors to predict placental abruption. Prenat Diagn. 2007;27:1143–6.
   PubMed Web of Science ®Google Scholar
• Tikkanen M, Surcel H-M, Bloigu A, Nuutila M, Hiilesmaa V, Ylikorkala O, Prediction of placental abruption by testing for C-reactive protein and chlamydial antibody levels in early pregnancy. BJOG. 2008;115:486–91.
   PubMedGoogle Scholar
• Signore C, Mills JL, Qian C, Yu KF, Rana S, Karumanchi SA, Circulating soluble endoglin and placental abruption. Prenat Diagn. 2008;28:852–8.
   PubMed Web of Science ®Google Scholar
• Steinborn A, Seidl C, Sayehli C, Sohn C, Seifried E, Kaufmann M, Anti-fetal immune response mechanisms may be involved in the pathogenesis of placental abruption. Clin Immunol. 2004;110:45–54.
   Google Scholar
• Nielsen HS, Mogensen M, Steffensen R, Kruse C, Christiansen OB. Indications of anti-HY immunity in recurrent placental abruption. J Reprod Immunol. 2007;75:63–9.
   Google Scholar
• Steinborn A, Rebmann V, Scharf A, Sohn C, Grosse-Wilde H. Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G. J Clin Immunol. 2003;23:307–14.
   PubMedGoogle Scholar
• Rosen T, Schatz F, Kuczynski E, Lam H, Koo AB, Lockwood CJ. Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes. J Matern Fetal Neonatal Med. 2002;11:11–17.
   PubMedGoogle Scholar
• Dommisse J, Tiltman AJ. Placental bed biopsies in placental abruption. BJOG. 1992;99:651–4.
   Google Scholar
• Elliott JP, Gilpin B, Strong TH Jr, Finberg HJ. Chronic abruption-oligohydramnios sequence. J Reprod Med. 1998;43:418–22.
   PubMed Web of Science ®Google Scholar
• Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12:642–9.
   PubMed Web of Science ®Google Scholar
• Konje JC, Taylor DJ. Bleeding in late pregnancy. In: James DK, Steer PJ, Weiner CP, Gonik B (eds). High risk pregnancy. 3rd edn. Edinburgh, UK: WB Saunders Co, 2006. pp. 1259–75.
   Google Scholar
• Baron F, Hill WC. Placenta previa, placenta abruptio. Clin Obstet Gynecol. 1998;41:527–32.
   PubMedGoogle Scholar
• Hurd WW, Miodovnik M, Hertzberg V, Lavin JP. Selective management of abruptio placentae: a prospective study. Obstet Gynecol. 1983;61:467–73.
   PubMed Web of Science ®Google Scholar
• Page EW, King EB, Merrill JA. Abruptio placentae: dangers of delay in delivery. Obstet Gynecol. 1954;3:385–93.
   Google Scholar
• Nyberg DA, Cyr DR, Mack LA, Wilson DA, Shuman WP. Sonographic spectrum of placental abruption. Am J Roentgenol. 1987;148:161–4.
   PubMed Web of Science ®Google Scholar
• Glantz C, Purnell L. Clinical utility of sonography in the diagnosis and treatment of placental abruption. J Ultrasound Med. 2002;21:837–40.
   PubMed Web of Science ®Google Scholar
• Manolitsas T, Wein P, Beischer NA, Sheedy MT, Ratten VJ. Value of cardiotocography in women with antepartum haemorrhage--is it too late for caesarean section when the cardiotocograph shows ominous features? Aust N Z J Obstet Gynaecol. 1994;34:403–8.
   Google Scholar
• Kaminsky LM, Ananth CV, Prasad V, Nath C, Vintzileos AM, New Jersey Placental Abruption Study Investigators. The influence of maternal cigarette smoking on placental pathology in pregnancies complicated by abruption. Am J Obstet Gynecol. 2007;197:275. e1–5.
   Google Scholar
• Nath CA, Ananth CV, Smulian JC, Shen-Schwarz S, Kaminsky L, New Jersey-Placental Abruption Study Investigators. Histologic evidence of inflammation and risk of placental abruption. Am J Obstet Gynecol. 2007;197:319. e1–6.
   PubMedGoogle Scholar
• Darby MJ, Caritis SN, Shen-Schwarz S. Placental abruption in the preterm gestation: an association with chorioamnionitis. Obstet Gynecol. 1989;74:88–92.
   PubMed Web of Science ®Google Scholar
• Lindqvist PG, Happach C. Risk and risk estimation of placental abruption. Eur J Obstet Gynecol Reprod Biol. 2006;126:160–4.
   PubMed Web of Science ®Google Scholar
• Toivonen S, Keski-Nisula L, Saarikoski S, Heinonen S. Risk of placental abruption in first-degree relatives of index patients. Clin Genet. 2004;66:244–6.
   Google Scholar
• Rasmussen S, Irgens LM. Occurrence of placental abruption in relatives. BJOG. 2009;116:693–9.
   PubMed Web of Science ®Google Scholar
• Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, The Thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006;132:171–96.
   PubMed Web of Science ®Google Scholar
• Zdoukopoulos N, Zintzaras E. Genetic risk factors for placental abruption a HuGe review and meta-analysis. Epidemiology. 2008;19:309–23.
   PubMedGoogle Scholar
• Prochazka M, Happach C, Marsal K, Dahlback B, Lindqvist PG. Factor V Leiden in pregnancies complicated by placental abruption. BJOG. 2003;110:462–6.
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Yoshimura M, Tabata A, Yasue H, Okamura H. The missense Glu298Asp variant of the endothelial nitric oxide synthase gene is strongly associated with placental abruption. Hum Genet. 2001;108:181–3.
   PubMed Web of Science ®Google Scholar
• Hillermann R, Carelse K, Gebhardt GS. The Glu298Asp variant of the endothelial nitric oxide synthase gene is associated with an increased risk for abruptio placentae in pre-eclampsia. J Hum Genet. 2005;50:415–9.
   PubMed Web of Science ®Google Scholar
• Toivonen S, Keski-Nisula L, Romppanen EL, Helisalmi S, Punnonen K, Heinonen S. Endothelial nitric oxide synthase polymorphism is not associated with placental abruption in Finnish women. Fetal Diagn Ther. 2005;20:508–11.
   Google Scholar
• Toivonen S, Romppanen EL, Hiltunen M, Helisalmi S, Keski-Nisula L, Punnonen K, Low-activity haplotype of the microsomal epoxide hydrolase gene is protective against placental abruption. J Soc Gynecol Investig. 2004;11:540–4.
   Google Scholar
• Ananth CV, Savitz DA, Williams MA. Placental abruption and its association with hypertension and prolonged rupture of membranes: a methodologic review and meta-analysis. Obstet Gynecol. 1996;88:309–18.
   PubMed Web of Science ®Google Scholar
• Kåregård M, Gennser G. Incidence and recurrence rate of abruptio placentae in Sweden. Obstet Gynecol. 1986;67:523–8.
   PubMed Web of Science ®Google Scholar
• Rasmussen S, Irgens LM, Dalaker K. The effect on the likelihood of further pregnancy of placental abruption and the rate of its recurrence. BJOG. 1997;104:1292–5.
   Web of Science ®Google Scholar
• Ananth CV, Cnattingius S. Influence of maternal smoking on placental abruption in successive pregnancies: a population-based prospective cohort study in Sweden. Am J Epidemiol. 2007;166:289–95.
   Google Scholar
• Rasmussen S, Irgens LM, Dalaker K. Outcome of pregnancies subsequent to placental abruption: a risk assessment. Acta Obstet Gynecol Scand. 2000;79:496–501.
   PubMed Web of Science ®Google Scholar
• Toivonen S, Heinonen S, Anttila M, Kosma VM, Saarikoski S. Obstetric prognosis after placental abruption. Fetal Diagn Ther. 2004;19:336-41.
   PubMed Web of Science ®Google Scholar
• Harrington K, Cooper D, Lees C, Hecher K Campbell S. Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstet Gynecol. 1996;7:182-8.
   PubMed Web of Science ®Google Scholar
• Pilalis A, Souka AP, Antsaklis P, Daskalakis G, Papantoniou N, Mesogitis S, Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation. Ultrasound Obstet Gynecol. 2007;29:135–40.
   PubMed Web of Science ®Google Scholar
• Vasapollo B, Novelli GP, Valensise H. Total vascular resistance and left ventricular morphology as screening tools for complications in pregnancy. Hypertension. 2008;51:1020–6.
   PubMed Web of Science ®Google Scholar
• Katz VL, Chescheir NC, Cefalo RC. Unexplained elevations of maternal serum alpha-fetoprotein. Obstet Gynecol Surv. 1990;45:719–26.
   PubMedGoogle Scholar
• van Rijn M, van der Schouw YT, Hagenaars AM, Visser GH, Christiaens GC. Adverse obstetric outcome in low- and high- risk pregnancies: predictive value of maternal serum screening. Obstet Gynecol. 1999;94:929–34.
   PubMedGoogle Scholar
• Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol. 2004;191:1446–51.
   PubMed Web of Science ®Google Scholar
• Toivonen S, Heinonen S, Anttila M, Kosma VM, Saarikoski S. Reproductive risk factors, Doppler findings, and outcome of affected births in placental abruption: a population-based analysis. Am J Perinatol. 2002;19:451–60.
   PubMed Web of Science ®Google Scholar
• Salafia CM, Silberman L, Herrera NE, Mahoney MJ. Placental pathology at term associated with elevated midtrimester maternal serum alpha-fetoprotein concentration. Am J Obstet Gynecol. 1988;158:1064–6.
   PubMed Web of Science ®Google Scholar
• Liu DF, Dickerman LH, Redline RW. Pathologic findings in pregnancies with unexplained increases in midtrimester maternal serum human chorionic gonadotropin levels. Am J Clin Pathol. 1999;111:209–15.
   PubMed Web of Science ®Google Scholar
• Keelan JA, Taylor R, Schellenberg JC, Groome NP, Mitchell MD, North RA. Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies. Obstet Gynecol. 2002;99:267–74.
   PubMed Web of Science ®Google Scholar
• Madazli R, Kuseyrioglu B, Uzun H, Uludag S, Ocak V. Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry. Int J Gynaecol Obstet. 2005;89:251–7.
   PubMed Web of Science ®Google Scholar
• Kanayama N, Terao T. Plasma fibronectin receptor levels during pregnancy complicated by preeclampsia and abruptio placentae. Gynecol Obstet Investig. 1992;33:147–52.
   Google Scholar
• Magriples U, Chan DW, Bruzek D, Copel JA, Hsu CD. Thrombomodulin: a new marker for placental abruption. Thromb Haemost. 1999;81:32–4.
   Google Scholar
• Emery CL, Morway LF, Chung-Park M, Wyatt-Ashmead J, Sawady J, Beddow TD. The Kleihauer-Betke test. Clinical utility, indication, and correlation in patients with placental abruption and cocaine use. Arch Pathol Lab Med. 1995;119:1032–7.
   PubMedGoogle Scholar
• Adema E, Gebert U. Pooled patient samples as reference material for D-Dimer. Thromb Res. 1995;80:85–8.
   Google Scholar
• Baumann P, Blackwell SC, Schild C, Berry SM, Friedrich HJ. Mathematic modeling to predict abruptio placentae. Am J Obstet Gynecol. 2000;183:815–22.
   PubMed Web of Science ®Google Scholar
• Rasmussen S, Irgens LM, Albrechtsen S, Dalaker K. Women with a history of placental abruption: when in a subsequent pregnancy should special surveillance for a recurrent placental abruption be initiated? Acta Obstet Gynecol Scand. 2001;80:708–12.
   PubMed Web of Science ®Google Scholar